A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation

A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation

10.1016/j.canlet.2016.07.023

Saved in:

Bibliographic Details
Main Authors:	Ong, Pei-Shi, Wang, Lingzhi, Chia, Deborah Miao-Hui, Seah, Jolyn Yu-Xin, Kong, Li-Ren, Thuya, Win-Lwin, Chinnathambi, Arunachalam, Lau, Jie-Ying Amelia, Wong, Andrea Li-Ann, Yong, Wei-Peng, Yang, Daiwen, Ho, Paul Chi-Lui, Sethi, Gautam, Goh, Boon-Cher
Other Authors:	BIOLOGY (NU)
Format:	Article
Language:	English
Published:	ELSEVIER IRELAND LTD 2020
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Belinostat (R) Seliciclib (R) Non-small cell lung cancer Caspase-8 activation Truncated BID HISTONE DEACETYLASE INHIBITORS DEPENDENT KINASE INHIBITOR DEATH P53 FLAVOPIRIDOL ENHANCEMENT CARBOPLATIN ROSCOVITINE EXPRESSION PACLITAXEL
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/175510
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Be the first to leave a comment!